193 related articles for article (PubMed ID: 31631317)
1. Awakening dormant glycosyltransferases in CHO cells with CRISPRa.
Karottki KJC; Hefzi H; Xiong K; Shamie I; Hansen AH; Li S; Pedersen LE; Li S; Lee JS; Lee GM; Kildegaard HF; Lewis NE
Biotechnol Bioeng; 2020 Feb; 117(2):593-598. PubMed ID: 31631317
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9 gene editing for the creation of an MGAT1-deficient CHO cell line to control HIV-1 vaccine glycosylation.
Byrne G; O'Rourke SM; Alexander DL; Yu B; Doran RC; Wright M; Chen Q; Azadi P; Berman PW
PLoS Biol; 2018 Aug; 16(8):e2005817. PubMed ID: 30157178
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9 as a Genome Editing Tool for Targeted Gene Integration in CHO Cells.
Sergeeva D; Camacho-Zaragoza JM; Lee JS; Kildegaard HF
Methods Mol Biol; 2019; 1961():213-232. PubMed ID: 30912048
[TBL] [Abstract][Full Text] [Related]
4. Application of the CRISPR/Cas9 Gene Editing Method for Modulating Antibody Fucosylation in CHO Cells.
Wang Q; Aliyu L; Chung CY; Rosenberg JN; Yu G; Betenbaugh MJ
Methods Mol Biol; 2024; 2810():249-271. PubMed ID: 38926284
[TBL] [Abstract][Full Text] [Related]
5. Application of the CRISPR/Cas9 Gene Editing Method for Modulating Antibody Fucosylation in CHO Cells.
Wang Q; Chung CY; Rosenberg JN; Yu G; Betenbaugh MJ
Methods Mol Biol; 2018; 1850():237-257. PubMed ID: 30242691
[TBL] [Abstract][Full Text] [Related]
6. Application of CRISPR/Cas9 Genome Editing to Improve Recombinant Protein Production in CHO Cells.
Grav LM; la Cour Karottki KJ; Lee JS; Kildegaard HF
Methods Mol Biol; 2017; 1603():101-118. PubMed ID: 28493126
[TBL] [Abstract][Full Text] [Related]
7. Expanding the CRISPR toolbox for Chinese hamster ovary cells with comprehensive tools for Mad7 genome editing.
Rojek JB; Basavaraju Y; Nallapareddy S; Bulté DB; Baumgartner R; Schoffelen S; Grav LM; Goletz S; Pedersen LE
Biotechnol Bioeng; 2023 Jun; 120(6):1478-1491. PubMed ID: 36864663
[TBL] [Abstract][Full Text] [Related]
8. Glyco-engineered CHO cell lines producing alpha-1-antitrypsin and C1 esterase inhibitor with fully humanized N-glycosylation profiles.
Amann T; Hansen AH; Kol S; Hansen HG; Arnsdorf J; Nallapareddy S; Voldborg B; Lee GM; Andersen MR; Kildegaard HF
Metab Eng; 2019 Mar; 52():143-152. PubMed ID: 30513349
[TBL] [Abstract][Full Text] [Related]
9. Accelerated generation of gene-engineered monoclonal CHO cell lines using FluidFM nanoinjection and CRISPR/Cas9.
Antony JS; Herranz AM; Mohammadian Gol T; Mailand S; Monnier P; Rottenberger J; Roig-Merino A; Keller B; Gowin C; Milla M; Beyer TA; Mezger M
Biotechnol J; 2024 Apr; 19(4):e2300505. PubMed ID: 38651269
[TBL] [Abstract][Full Text] [Related]
10. A Site-Specific Integration Reporter System That Enables Rapid Evaluation of CRISPR/Cas9-Mediated Genome Editing Strategies in CHO Cells.
Hamaker NK; Lee KH
Biotechnol J; 2020 Aug; 15(8):e2000057. PubMed ID: 32500600
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas9-mediated genome engineering of CHO cell factories: Application and perspectives.
Lee JS; Grav LM; Lewis NE; Faustrup Kildegaard H
Biotechnol J; 2015 Jul; 10(7):979-94. PubMed ID: 26058577
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9-Multiplexed Editing of Chinese Hamster Ovary B4Gal-T1, 2, 3, and 4 Tailors N-Glycan Profiles of Therapeutics and Secreted Host Cell Proteins.
Amann T; Hansen AH; Kol S; Lee GM; Andersen MR; Kildegaard HF
Biotechnol J; 2018 Oct; 13(10):e1800111. PubMed ID: 29862652
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas12a-mediated CHO genome engineering can be effectively integrated at multiple stages of the cell line generation process for bioproduction.
Schweickert PG; Wang N; Sandefur SL; Lloyd ME; Konieczny SF; Frye CC; Cheng Z
Biotechnol J; 2021 Apr; 16(4):e2000308. PubMed ID: 33369118
[TBL] [Abstract][Full Text] [Related]
14. High throughput, efficacious gene editing & genome surveillance in Chinese hamster ovary cells.
Huhn SC; Ou Y; Kumar A; Liu R; Du Z
PLoS One; 2019; 14(12):e0218653. PubMed ID: 31856197
[TBL] [Abstract][Full Text] [Related]
15. Glycoengineering of CHO Cells to Improve Product Quality.
Wang Q; Yin B; Chung CY; Betenbaugh MJ
Methods Mol Biol; 2017; 1603():25-44. PubMed ID: 28493121
[TBL] [Abstract][Full Text] [Related]
16. Improving recombinant protein production in CHO cells using the CRISPR-Cas system.
Kalkan AK; Palaz F; Sofija S; Elmousa N; Ledezma Y; Cachat E; Rios-Solis L
Biotechnol Adv; 2023; 64():108115. PubMed ID: 36758652
[TBL] [Abstract][Full Text] [Related]
17. Multicopy Targeted Integration for Accelerated Development of High-Producing Chinese Hamster Ovary Cells.
Sergeeva D; Lee GM; Nielsen LK; Grav LM
ACS Synth Biol; 2020 Sep; 9(9):2546-2561. PubMed ID: 32835482
[TBL] [Abstract][Full Text] [Related]
18. One-step generation of triple knockout CHO cell lines using CRISPR/Cas9 and fluorescent enrichment.
Grav LM; Lee JS; Gerling S; Kallehauge TB; Hansen AH; Kol S; Lee GM; Pedersen LE; Kildegaard HF
Biotechnol J; 2015 Sep; 10(9):1446-56. PubMed ID: 25864574
[TBL] [Abstract][Full Text] [Related]
19. CRISPR-Based Targeted Epigenetic Editing Enables Gene Expression Modulation of the Silenced Beta-Galactoside Alpha-2,6-Sialyltransferase 1 in CHO Cells.
Marx N; Grünwald-Gruber C; Bydlinski N; Dhiman H; Ngoc Nguyen L; Klanert G; Borth N
Biotechnol J; 2018 Oct; 13(10):e1700217. PubMed ID: 29802757
[TBL] [Abstract][Full Text] [Related]
20. Glycoengineering of Chinese hamster ovary cells for enhanced erythropoietin N-glycan branching and sialylation.
Yin B; Gao Y; Chung CY; Yang S; Blake E; Stuczynski MC; Tang J; Kildegaard HF; Andersen MR; Zhang H; Betenbaugh MJ
Biotechnol Bioeng; 2015 Nov; 112(11):2343-51. PubMed ID: 26154505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
